These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Vagal nerve stimulation increases right ventricular contraction and relaxation and heart rate. Henning RJ; Feliciano L; Coers CM Cardiovasc Res; 1996 Nov; 32(5):846-53. PubMed ID: 8944815 [TBL] [Abstract][Full Text] [Related]
7. Vagal stimulation during muscarinic and beta-adrenergic blockade increases atrial contractility and heart rate. Henning RJ J Auton Nerv Syst; 1992 Sep; 40(2):121-9. PubMed ID: 1464693 [TBL] [Abstract][Full Text] [Related]
8. Cardiac responses to VIP and VIP-ergic-cholinergic interaction in isolated dog heart preparations. Karasawa Y; Furukawa Y; Ren LM; Takei M; Murakami M; Narita M; Chiba S Eur J Pharmacol; 1990 Oct; 187(1):9-17. PubMed ID: 2272357 [TBL] [Abstract][Full Text] [Related]
9. Myocardial and gastrointestinal release of vasoactive intestinal peptide during experimental acute myocardial infarction. Gyöngyösi M; Kaszaki J; Németh J; Wolfárd A; Mojzes L; Farkas A Coron Artery Dis; 1997 Jun; 8(6):335-41. PubMed ID: 9347213 [TBL] [Abstract][Full Text] [Related]
10. Release of vasoactive intestinal peptide and neuropeptide Y from canine heart. Anderson FL; Kralios AC; Reid B; Hanson GR Am J Physiol; 1993 Sep; 265(3 Pt 2):H959-65. PubMed ID: 8214133 [TBL] [Abstract][Full Text] [Related]
15. Effect of vasoactive intestinal peptide on myocardial contractility and coronary blood flow in the dog: comparison with isoproterenol and forskolin. Anderson FL; Kralios AC; Hershberger R; Bristow MR J Cardiovasc Pharmacol; 1988 Sep; 12(3):365-71. PubMed ID: 2464111 [TBL] [Abstract][Full Text] [Related]
16. Vasoactive intestinal peptide: vasodilatation and cyclic AMP generation. Ganz P; Sandrock AW; Landis SC; Leopold J; Gimbrone MA; Alexander RW Am J Physiol; 1986 May; 250(5 Pt 2):H755-60. PubMed ID: 3010741 [TBL] [Abstract][Full Text] [Related]
17. Vasoactive intestinal peptide in bovine pulmonary artery: localisation, function and receptor autoradiography. Barnes PJ; Cadieux A; Carstairs JR; Greenberg B; Polak JM; Rhoden K Br J Pharmacol; 1986 Sep; 89(1):157-62. PubMed ID: 3026543 [TBL] [Abstract][Full Text] [Related]
18. Effect of vasoactive intestinal polypeptide on the canine cardiovascular system. Unverferth DV; O'Dorisio TM; Muir WW; White J; Miller MM; Hamlin RL; Magorien RD J Lab Clin Med; 1985 Nov; 106(5):542-50. PubMed ID: 4056568 [TBL] [Abstract][Full Text] [Related]
19. The in vitro chronotropic and inotropic effects of vasoactive intestinal peptide (VIP) on the atria and ventricular papillary muscle from Cynomolgus monkey heart. De Neef P; Robberecht P; Chatelain P; Waelbroeck M; Christophe J Regul Pept; 1984 Apr; 8(3):237-44. PubMed ID: 6463285 [TBL] [Abstract][Full Text] [Related]
20. Desensitization of myocardial but not coronary VIP receptor-mediated responses in dogs. Anderson FL; Kralios AC; Hershberger R; Bristow MR Am J Physiol; 1988 Sep; 255(3 Pt 2):H601-7. PubMed ID: 2843056 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]